Page last updated: 2024-08-25

bexarotene and Graft-Versus-Host Disease

bexarotene has been researched along with Graft-Versus-Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chemnitz, J; Kurschat, P; Scheid, C; Schlaak, M; Shimabukuro-Vornhagen, A; Stadler, R; Theurich, S; von Bergwelt-Baildon, M	1

Other Studies

1 other study(ies) available for bexarotene and Graft-Versus-Host Disease

Article	Year
Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation. Transplant immunology, 2011, Volume: 25, Issue:2-3 Topics: Adult; Bexarotene; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Lymphocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Photopheresis; PUVA Therapy; Recurrence; Skin Neoplasms; Tetrahydronaphthalenes	2011

Article

Year

Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.

Transplant immunology, 2011, Volume: 25, Issue:2-3

Topics: Adult; Bexarotene; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Lymphocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Photopheresis; PUVA Therapy; Recurrence; Skin Neoplasms; Tetrahydronaphthalenes

2011